DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
265	脂肪萎縮症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00082628 (ClinicalTrials.gov)	May 2004	13/5/2004	Treatment of Abnormal Adipose Tissue Accumulation in HIV Patients	A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety and Efficacy of Serostim®, r-hGH in the Treatment and Maintenance of Human Immunodeficiency HIV-Associated Adipose Redistribution Syndrome, or HARS	HIV Infections;Lipodystrophy	Drug: Serostim®[somatropin (rDNA origin) for injection]	EMD Serono	NULL	Completed	18 Years	60 Years	Both	569	Phase 3	United States;Canada

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00082628
(ClinicalTrials.gov)

May 2004

13/5/2004

Treatment of Abnormal Adipose Tissue Accumulation in HIV Patients

A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety and Efficacy of Serostim®, r-hGH in the Treatment and Maintenance of Human Immunodeficiency HIV-Associated Adipose Redistribution Syndrome, or HARS

HIV Infections;Lipodystrophy

Drug: Serostim®[somatropin (rDNA origin) for injection]

EMD Serono

NULL

Completed

18 Years

60 Years

Both

569

Phase 3

United States;Canada